Core A: Administrative Core
核心A:行政核心
基本信息
- 批准号:10591543
- 负责人:
- 金额:$ 110.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdvisory CommitteesAlzheimer&aposs DiseaseAnimal WelfareBiological MarkersClinicalCommunitiesDedicationsDevelopmentDiseaseEducation and OutreachEnvironmentFosteringFundingGoalsGrowthImageIndividualInfrastructureInternationalLeadershipMentorsNational Institute on AgingPoliciesPositioning AttributeProductivityResearchResearch PersonnelResearch Project GrantsResearch SupportResource AllocationResourcesScientistSpecimenStrategic PlanningTrainingUnited States National Institutes of HealthUtilization ReviewWorkcatalystdata managementdata sharingeducation researchhuman subject protectioninnovationmembermodel organismneuropathologyoutreachprogramsrecruitstatisticssuccess
项目摘要
ADMINISTRATIVE CORE: CORE A - PROJECT SUMMARY/ ABSTRACT
The Administrative Core is central to the success of the JHADRC as it provides: (1) the overall direction and
strategic planning for the Center, (2) the infrastructure and core resources that accelerate research (3)
coordination of interactions between Cores and the Johns Hopkins scientific community, and (4) leadership for
interactions of the JHADRC with the national network of AD centers and national programs. The leadership of
the JHADRC remains strong and stable, with Dr. Marilyn Albert serving as Director, and Drs. Constantine
Lyketsos and Philip Wong as Associate Directors, positions they have held for more than 10 years. Four of the
six core leaders are the same as in the prior funding cycle, including: Dr. Albert (Administrative Core, Leader),
Dr. Lyketsos (Clinical Core, Leader), Dr. Karen-Bandeen-Roche (Data Management and Statistics Core,
Leader), Dr. Juan Troncoso (Neuropathology Core, Leader). Dr. Corinne Pettigrew will assume the leadership
of the Outreach, Recruitment and Engagement Core, after having served as Co-Leader for several years. In
this funding cycle, a Biomarker Core will be added (Dr. Arnold Bakker, Leader) and a Research Education
Component (Dr. Paul Worley, Leader). The Cores and the REC interact in order to accomplish the ADRC goals.
Organizational and strategic planning for the Center depends upon an Executive Committee that meets
monthly, which consists of all of the Core and REC Leaders and Co-Leaders. A Financial Advisory Committee
meets quarterly. Oversight of the Center is provided by an External Advisory Committee that meets annually,
and an Internal Scientific Advisory Committee that meets bi-annually. The Executive Committee, with input
from the Internal Scientific Advisory Committee, will select three Developmental Projects for funding (one
project for two years and two projects for three years each). Through strategic planning by members of the
Executive Committee of the JHADRC many new core resources have been developed in the past 4 years that
will facilitate research and training in the next funding cycle, which are described in the Administrative Core.
行政核心:核心A-项目摘要/摘要
行政核心是JHADRC成功的核心:(1)总体方向和
该中心的战略规划,(2)加速研究的基础设施和核心资源(3)
核心与约翰·霍普金斯科学界之间的互动协调,(4)领导
JHADRC与国家广告中心和国家计划的国家网络的互动。领导
Jhadrc仍然坚强而稳定,玛丽莲·阿尔伯特(Marilyn Albert)博士担任董事和博士。君士坦丁
Lyketsos和Philip Wong担任副董事,他们担任了十多年的职位。四个
六个核心领导者与先前的资助周期相同,包括:阿尔伯特博士(行政核心,领导者),
Lyketsos博士(临床核心,领导者),Karen-Bandeen-Roche博士(数据管理和统计核心,
领导者),胡安·特隆科索(Juan Troncoso)博士(神经病理学核心,领导者)。科琳·佩蒂格鲁(Corinne Pettigrew)博士将担任领导
在担任联合领导的几年后,外展,招聘和参与核心的核心。在
将添加这个资金周期,生物标志物核心(Arnold Bakker博士,领导者)和研究教育
组件(Paul Worley博士,领导者)。核心和REC相互作用是为了实现ADRC目标。
该中心的组织和战略规划取决于一个执行委员会
每月,由所有核心和REC领导者和共同领导者组成。财务咨询委员会
季刊。该中心的监督由每年开会的外部咨询委员会提供
以及一个双年会议的内部科学咨询委员会。执行委员会,有意见
从内部科学咨询委员会中,将选择三个发展项目以进行资金(一个
项目两年零两个项目,分别为三年)。通过成员的战略计划
Jhadrc执行委员会在过去的四年中已经建立了许多新的核心资源
将在下一个资金周期中促进研究和培训,这在行政核心中描述。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARILYN S. ALBERT其他文献
MARILYN S. ALBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARILYN S. ALBERT', 18)}}的其他基金
Johns Hopkins Alzheimer's Disease Research Center
约翰霍普金斯大学阿尔茨海默病研究中心
- 批准号:
9921614 - 财政年份:2020
- 资助金额:
$ 110.19万 - 项目类别:
Johns Hopkins Alzheimer's Disease Research Center
约翰·霍普金斯大学阿尔茨海默病研究中心
- 批准号:
10591542 - 财政年份:2020
- 资助金额:
$ 110.19万 - 项目类别:
Johns Hopkins Alzheimer's Disease Research Center
约翰·霍普金斯大学阿尔茨海默病研究中心
- 批准号:
10374071 - 财政年份:2020
- 资助金额:
$ 110.19万 - 项目类别:
Development of MRI microvascular biomarkers in cognitive impairment and dementia
认知障碍和痴呆 MRI 微血管生物标志物的开发
- 批准号:
10001049 - 财政年份:2016
- 资助金额:
$ 110.19万 - 项目类别:
Development of MRI microvascular biomarkers in cognitive impairment and dementia
认知障碍和痴呆 MRI 微血管生物标志物的开发
- 批准号:
9770571 - 财政年份:2016
- 资助金额:
$ 110.19万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10611828 - 财政年份:2016
- 资助金额:
$ 110.19万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10368371 - 财政年份:2016
- 资助金额:
$ 110.19万 - 项目类别:
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
验证小血管对认知障碍和痴呆 (VCID) 生物标志物的贡献
- 批准号:
10888591 - 财政年份:2016
- 资助金额:
$ 110.19万 - 项目类别:
相似海外基金
Multi-ethnic risk prediction for complex human diseases integrating multi-source genetic and non-genetic information
整合多源遗传与非遗传信息的人类复杂疾病多民族风险预测
- 批准号:
10754773 - 财政年份:2023
- 资助金额:
$ 110.19万 - 项目类别:
Microvascular Neuroimaging in Age-related Alzheimer's Disease and Tauopathies
年龄相关性阿尔茨海默病和 Tau蛋白病的微血管神经影像学
- 批准号:
10738372 - 财政年份:2023
- 资助金额:
$ 110.19万 - 项目类别:
Investigating the role of sleep in brain resilience during aging using a scalable and short-lived vertebrate model
使用可扩展且寿命较短的脊椎动物模型研究睡眠在衰老过程中大脑恢复能力中的作用
- 批准号:
10740068 - 财政年份:2023
- 资助金额:
$ 110.19万 - 项目类别:
Exploring brain perivascular fibroblasts in health and cerebral amyloid angiopathy
探索大脑血管周围成纤维细胞在健康和脑淀粉样血管病中的作用
- 批准号:
10739076 - 财政年份:2023
- 资助金额:
$ 110.19万 - 项目类别: